A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLELGROUP, ADULT LABORATORY CLASSROOM STUDY TO EVALUATE THE SAFETY AND EFFICACY OF PRC-063 COMPARED TO PLACEBO IN ADULTS WITH ADHD
Clinical Trial Grant
Administered By
Psychiatry, Child & Family Mental Health & Community Psychiatry
Awarded By
Purdue Pharma
Start Date
December 12, 2018
End Date
April 30, 2020
Administered By
Psychiatry, Child & Family Mental Health & Community Psychiatry
Awarded By
Purdue Pharma
Start Date
December 12, 2018
End Date
April 30, 2020